MLYS Dividend History & Analysis | N/A Yield

MLYS has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.

As of November 2025, Mineralys Therapeutics (MLYS) does not pay a dividend.

Top Dividend Payers in Biotechnology

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap (USD) Dividend Yield TTM Yield on Cost (purchase 5y ago)
JBIO 280 M 20.9% 0.31%
GILD 155,333 M 3.14% 7.99%
ABBV 410,546 M 2.86% 7.80%
AMGN 180,930 M 2.83% 4.98%
HLN 44,016 M 1.83% 2.46%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap (USD) Growth Rate (CAGR) Payout Consistency
GRFS 7,645 M 127% 60.7%
HLN 44,016 M 51.0% 100%
AMGN 180,930 M 8.90% 100%
ABBV 410,546 M 7.06% 100%
GILD 155,333 M 3.16% 100%

Similar Stocks with Attractive Dividends - Compare MLYS Dividends with its Peer-Group

ABBV
AbbVie
2.86% Yield
AMGN
Amgen
2.83% Yield
GILD
Gilead Sciences
3.14% Yield
HLN
Haleon
1.83% Yield

MLYS Dividend History: as of November 2025

No dividends paid yet.

MLYS Dividend FAQ

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is a U.S. clinical-stage biopharma focused on diseases driven by excess aldosterone. Its lead asset, lorundrostat, is an oral, highly selective aldosterone-synthase inhibitor being pursued for hypertension, chronic kidney disease (CKD) and obstructive sleep apnea.

What is the Dividend Yield of MLYS?

As of November 2025, MLYS`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 41.87.

Does MLYS pay a dividend?

As of November 2025 MLYS does not pay a dividend.

How often does MLYS pay dividends?

Over the last 12 months, MLYS has issued dividend payments.

Will MLYS pay dividends in 2025?

The next Ex-Dividend date for Mineralys Therapeutics (MLYS) is currently unknown.

What is the next Ex-Dividend Date for MLYS?

The next Ex-Dividend date for Mineralys Therapeutics (MLYS) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of MLYS?

MLYS's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of MLYS?

MLYS's 5-Year Yield on Cost is -%. If you bought MLYS's shares at 16.00 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of MLYS?

MLYS Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.

Does MLYS have a good Dividend Yield?

MLYS`s % Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of MLYS?

The Dividend Payout Ratio of MLYS is unknown.

What is the Dividend Rating of MLYS?

MLYS`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

MLYS Outstanding Shares Analysis

What is the Trend in MLYS`s Outstanding Shares (CAGR)?

Mineralys Therapeutics`s outstanding shares have increased by approximately 213.05% annually over the past 3 years (Correlation: 100.0%), negatively influencing the share price.

Has Mineralys Therapeutics ever had a Stock Split?

No Stock Splits found.
Year Number of Shares Annual Growth Rate
2020 5,000,000
2021 5,000,000
2022 5,000,000
2023 36,000,000 +620%
2024 49,000,000 +36.11%

Key Metric Definitions

  • Dividend Yield: Annual dividend per share divided by current share price.
  • Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
  • Payout Ratio: Percentage of earnings paid as dividends (TTM).
  • Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
  • Payout Frequency: Number of dividends paid in the last 12m (TTM).
  • Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
  • Total Return: Price appreciation plus dividends over specified period.
  • Market Cap: Figures are in millions of the corresponding currency.

Last update: 2025-11-11 10:38